ACIP Presentation Slides: February 4, 2022 Meeting

Note: These files are not yet 508

Slides will be added as they become available.

February 4, 2022

Welcome & Introductions

• Introduction
  Dr. G Lee
  Dr. M Wharton

Coronavirus Disease (COVID-19) Vaccines

• Introduction [13 pages]
  Dr. M Daley
  
• mRNA 1273 COVID-19 vaccine BLA safety and efficacy data [30 pages]
  Dr. R Das
• Updates on myocarditis and pericarditis following Moderna COVID-19 vaccination [19 pages]
  Dr. T Shimabukuro
• Update on myocarditis outcomes: MOVING [32 pages]
  Dr. I Kracalic
• VaST assessment [13 pages]
  Dr. K Talbot
• GRADE: Moderna COVID-19 vaccine [49 pages]
  Dr. M Wallace
• EtR Framework: Moderna COVID-19 vaccine primary series in adults ≥18 years of age [94 pages]
  Dr. S Oliver
• Updates to Clinical Considerations [21 pages]
  Dr. E Hall
• Canadian experience and evidence with COVID-19 vaccine primary series extended intervals [23 pages]
  Dr. M Tunis, Dr. B Warshawsky, Ms. S Ogunnaike-Cooke
• VSD: Myocarditis after Moderna and Pfizer/BioNTech COVID-19 vaccine [28 pages]
  Dr. N Klein
• Myocarditis and COVID-19 vaccine intervals: International data and policies [35 pages]
  Ms. D Moulia
• Summary and Work Group Interpretation: Extended intervals for mRNA COVID-19 vaccines [25 pages]
  Dr. S Oliver